Atlas Trials

A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee

Clinical trial NCT04044742 · WITHDRAWN

Trial details

NCT number
NCT04044742
Sponsor
Sorrento Therapeutics, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoarthritis, KneeKnee Pain Chronic
Start date
2020-12-01
Primary completion
2023-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.